Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

FFA is more common in postmenopausal women, can affect younger women, and may stabilize over time.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Folliculitis decalvans is a rare scalp condition causing scarring hair loss, treated with long-term antibiotics and other medications, but it often comes back and is hard to manage.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

FFA's causes may include environmental triggers and genetic factors.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Dermoscopy helps diagnose frontal fibrosing alopecia by distinguishing it from other hair loss conditions.

Hair loss is a rare but recognized symptom of pemphigus vulgaris, with patients usually regrowing hair after treatment.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.

Dermatoscopy helps diagnose hair and scalp disorders in people with Afro-textured hair, but more research is needed for better understanding and treatment.

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

Some treatments can stabilize Frontal Fibrosing Alopecia, but more research is needed to find effective treatments, and hair transplants often fail.

Infrared thermography, especially with dermoscopy, improves accuracy in diagnosing active hair loss due to inflammation.

Frontal Fibrosing Alopecia may be linked to autoimmune diseases like Sjögren's syndrome.

A mother and daughter with similar hair loss conditions and identical HLA types suggest a genetic link between the conditions.

Hair loss in autoimmune blistering skin diseases varies and may regrow with disease control.

Low-dose oral isotretinoin improved hair loss and facial bumps in patients with a specific type of hair loss.

Immune checkpoint inhibitors used in cancer therapy can cause hair loss, and understanding this can help manage the side effect.

Postmenopausal women can experience hairline recession, affecting their quality of life, and more research is needed for treatments.

Hidradenitis Suppurativa is a chronic skin condition best treated early with surgery for better outcomes and less recurrence.

Apremilast may help treat lichen planopilaris and frontal fibrosing alopecia when other treatments fail.

The document concludes that doctors should check for frontal fibrosing alopecia in patients with acquired hyperpigmentation and that early treatment is important.

Pseudopelade of Brocq is hard to diagnose and treat, with limited effective options.

Hair transplants can risk reactivating lichen planopilaris, a scarring hair loss condition.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

Some lung cancer patients treated with EGFR inhibitors may develop a hair loss condition similar to folliculitis decalvans.

A positive anagen pull test can help detect active Lichen Planopilaris.